Predict your next investment

Corporate Venture
merckghifund.com

See what CB Insights has to offer

Investments

93

Portfolio Exits

20

Funds

1

Partners & Customers

1

About Merck Global Health Innovation Fund

Merck Global Health Innovation Fund (Merck GHI) is evolving corporate healthcare venture capital globally by utilizing their healthcare ecosystem strategy. This investment strategy connects innovative companies with complementary technologies to develop integrated healthcare solutions. Merck Global Health Innovation Fund is part of Merck & Co. (NYSE: MRK).

Merck Global Health Innovation Fund Headquarter Location

Philadelphia, Pennsylvania,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Merck Global Health Innovation Fund

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Merck Global Health Innovation Fund in 1 CB Insights research brief, most recently on Jan 19, 2021.

Latest Merck Global Health Innovation Fund News

Syapse Raises $35M in Growth Funding

Jul 28, 2022

Syapse , a San Francisco, CA and New York-based evidence company dedicated to advancing real-world care, raised $35M in Growth funding. The round was led by Innovatus Capital Partners, with participation from existing investors including Ally Bridge Group, Merck Global Health Innovation Fund, Northpond Ventures, Revelation Alpine LLC, Safeguard Scientifics, and Social Capital. The company intends to use the funds to expand its focus on providing real-world insights to partners and assist them in improving outcomes for people with cancer. Led by Ken Tarkoff, chief executive officer, Syapse is a company dedicated to extinguishing the fear and burden of oncology and other serious diseases by advancing real-world care. By combining clinical expertise with smart technologies, the company transforms data into evidence—and then into experience—in collaboration with a network of partners, who are committed to improving patients’ lives through community health systems. Syapse has expanded its Learning Health Network by partnering with some of the nation’s leading community health systems to support precision medicine strategies that are directed at improving clinical outcomes, reducing costs and enhancing the experience of their patients. In addition, the company has added life sciences partnerships with established biopharmaceutical companies. FinSMEs 27/07/2022

Merck Global Health Innovation Fund Investments

93 Investments

Merck Global Health Innovation Fund has made 93 investments. Their latest investment was in Syapse as part of their Unattributed VC on July 7, 2022.

CBI Logo

Merck Global Health Innovation Fund Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/27/2022

Unattributed VC

Syapse

$35M

No

1

5/20/2022

Unattributed VC

Infectious Disease Connect

$5.45M

No

1

3/3/2022

Series B

CancerIQ

$14M

Yes

15

2/7/2022

Series C

Subscribe to see more

$99M

Subscribe to see more

10

1/25/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/27/2022

5/20/2022

3/3/2022

2/7/2022

1/25/2022

Round

Unattributed VC

Unattributed VC

Series B

Series C

Series A

Company

Syapse

Infectious Disease Connect

CancerIQ

Subscribe to see more

Subscribe to see more

Amount

$35M

$5.45M

$14M

$99M

$99M

New?

No

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

1

15

10

10

Merck Global Health Innovation Fund Portfolio Exits

20 Portfolio Exits

Merck Global Health Innovation Fund has 20 portfolio exits. Their latest portfolio exit was AbSci on July 22, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/22/2021

IPO

$99M

Public

6

6/9/2021

Merger

$99M

20

4/29/2021

Acquired

$99M

3

3/3/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

2/3/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/22/2021

6/9/2021

4/29/2021

3/3/2021

2/3/2021

Exit

IPO

Merger

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

6

20

3

10

10

Merck Global Health Innovation Fund Acquisitions

2 Acquisitions

Merck Global Health Innovation Fund acquired 2 companies. Their latest acquisition was Saama Technologies on October 20, 2021.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

10/20/2021

Debt

$99M

$79.25M

Acq - Fin

14

8/7/2013

Other Venture Capital

Subscribe to see more

$99M

$99M

Subscribe to see more

10

Date

10/20/2021

8/7/2013

Investment Stage

Debt

Other Venture Capital

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

$79.25M

$99M

Note

Acq - Fin

Subscribe to see more

Sources

14

10

Merck Global Health Innovation Fund Fund History

1 Fund History

Merck Global Health Innovation Fund has 1 fund, including Global Health Innovation Fund.

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/15/2011

Global Health Innovation Fund

Multi-Stage Venture Capital

Closed

$250M

1

Closing Date

9/15/2011

Fund

Global Health Innovation Fund

Fund Type

Multi-Stage Venture Capital

Status

Closed

Amount

$250M

Sources

1

Merck Global Health Innovation Fund Partners & Customers

1 Partners and customers

Merck Global Health Innovation Fund has 1 strategic partners and customers. Merck Global Health Innovation Fund recently partnered with Exostar on October 10, 2015.

Date

Type

Business Partner

Country

News Snippet

Sources

10/27/2015

Partner

United States

Exostar receives additional 10 USD million investment from Merck Global Health Innovation Fund

Exostar is that partner , and we are pleased Merck Global Health Innovation Fund has chosen once again to support us . ''

2

Date

10/27/2015

Type

Partner

Business Partner

Country

United States

News Snippet

Exostar receives additional 10 USD million investment from Merck Global Health Innovation Fund

Exostar is that partner , and we are pleased Merck Global Health Innovation Fund has chosen once again to support us . ''

Sources

2

Merck Global Health Innovation Fund Team

5 Team Members

Merck Global Health Innovation Fund has 5 team members, including current Managing Director, Francesca Domenech Wuttke.

Name

Work History

Title

Status

Francesca Domenech Wuttke

Managing Director

Current

Joel Krikston

Managing Director

Current

Bill Taranto

Managing Director

Current

Prem Tumkosit

Managing Director

Current

Maxwell Kahn

Managing Director

Former

Name

Francesca Domenech Wuttke

Joel Krikston

Bill Taranto

Prem Tumkosit

Maxwell Kahn

Work History

Title

Managing Director

Managing Director

Managing Director

Managing Director

Managing Director

Status

Current

Current

Current

Current

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.